LOXL2 and cardiovascular disorder: Lysyl Oxidase-like2 (LOXL2), one of SRCR-SF, plays a key role in cardiovascular diseases, and directedly interacted with collagen IV and fibronectin to regulate deposition of extracellular matrix (ECM) components (Umana-Diaz et al., 2020).